Job title: Chief Executive Officer & Founder
Mary E. Dixon is the founder and CEO of Innovenn located in Madison, Wisconsin. The mission of Innovenn is to improve patient health by combining multi-source data with artificial intelligence to help diagnose, treat and manage rare disease. Innovenn also performs human factors testing of medical devices and medical device software.
Prior to launching Innovenn, Ms. Dixon was the founder and CEO of Cogent Pharma which provides project leadership in support of launching new innovations in the pharmaceutical, biotechnology and medical device industries. It was through this work Ms. Dixon was inspired to launch Innovenn recognizing that by applying artificial intelligence and machine learning to analyze massive data from pharmaceutical research, it is possible to help those suffering from rare disease.
Prior to starting her own companies, Ms. Dixon worked at Merck & Company in pharmaceutical clinical research and was involved in the development of fourteen new compounds.
With a passion for helping those with rare disease, Ms. Dixon can often be found on the speaking trail or leading panel discussions to share Innovenn’s insights and vision of how big data is the new frontier in rare disease diagnosis, treatment and monitoring.
Regulatory “Must Haves” When Developing Software as a Medical Device (SaMD) That Uses Machine Learning & Artificial Intelligence 1:15 pm
• From data to development; creating clinically meaningful software • Navigating developing US and International regulatory testing requirement and standards • The importance of Usability, Human Factors and User Interface testing in the development processRead more
day: Day Two